22nd Annual US HUPO Conference (Human Proteome Organization)
February 21 ā 25, 2026 | St. Louis, Missouri, USA
AFFINISEP BREAKFAST SEMINAR
Multiplexed Detection of Membranous Nephropathy Antigens in Clinical Practice
Monday, February 23, 2026 | 7:15 - 8:15 AM
Monday, February 23, 2026 | 7:15 - 8:15 AM
Multiplexed Detection of Membranous Nephropathy Antigens in Clinical Practice
This seminar will present innovative Affinisep SPE kits designed to streamline sample preparation in MS-based proteomics. During this breakfast seminar, we will have the pleasure of welcoming Dr. Aaron Storey, Director of the Mass Spectrometry lab at Arkana Laboratories.
Dr. Aaron Storey will present his work on the implementation of a membranous nephropathy typing assay on a triple quadrupole mass spectrometer in clinical practice, and will describe how the use of the BioSPEĀ® PurePep 96 well plates for microelution helped him minimize variances during the peptide desalting step of his protocol. By attending his talk, you will learn that:
Register for Affinisep Breakfast Seminar
Register and secure your seat now!
Please note that you will automatically be enrolled in our monthly newsletter by registering.
Unsubscribe at any time.
Affinisep develops and manufactures from A to Z high quality and ready-to-use microelution BioSPEĀ® kits to simplify sample preparation in proteomics workflows and help you achieve highly reliable results. Our wide range of formats and capacities allow us to cover a broad range of needs, from a few samples processed manually, to high throughput processing of hundreds of samples in clinical studies.
SPEAKER INFORMATION
Aaron Storey, Ph.D.
Dr. Aaron Storey joined Arkana Laboratories in 2023 to direct the Mass Spectrometry Laboratory and is interested in developing and applying mass spectrometry techniques in clinical settings to improve the practice of medicine and address clinical needs. His academic career has provided him with a broad knowledge base, spanning molecular biology, neuroscience, genetics, proteomics, statistics, and data science. His skill set combines the application of cutting-edge proteomics techniques to generate large datasets containing high-quality information with the use of programming languages and data analysis techniques to turn this information into actionable insights. Currently, Dr. Storey is working on translating a mass spectrometry-based assay for the clinical typing of membranous nephropathy into practice. Dr. Storey received his B.Sc. in Behavioral Neuroscience in 2010 from the University of Evansville and his Ph.D. in Biochemistry & Molecular Biology in 2017 from the University of Arkansas for Medical Sciences.
Email address: [email protected]